Novo Integrated Sciences Inc - SIC # 8069 - SPECIALTY HOSPITALS, EXCEPT PSYCHIATRIC

Ticker Exchange SIC # Website Latest Ticker
NVOS Nasdaq 8069 https://www.novointegrated.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Novo Integrated Sciences Inc

Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results - Apr 15th, 2024 8:30 pm
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement - Apr 11th, 2024 9:00 pm
Novo Integrated Sciences Provides Update on Certain Current Actions and Events - Mar 26th, 2024 6:30 pm
Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd. - Feb 21st, 2024 9:05 pm
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note - Feb 20th, 2024 7:00 pm
Novo Integrated Sciences Appoints New President - Feb 16th, 2024 7:00 pm
Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results - Jan 22nd, 2024 9:30 pm
Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences - Dec 19th, 2023 9:30 pm
Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results - Dec 14th, 2023 10:00 pm
Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India - Dec 5th, 2023 5:00 pm
Novo Integrated Sciences’ Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval - Dec 4th, 2023 4:30 pm
Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement - Nov 24th, 2023 2:20 pm
Novo Integrated Sciences Announces Reverse Stock Split - Nov 6th, 2023 4:45 pm
Novo Integrated Sciences Advised Receipt of Proceeds of RC Consulting Promissory Note Expected in 3-5 Business Days - Nov 6th, 2023 11:00 am
Novo Integrated Sciences Announces Issuance of Underlying One Billion Dollar Gold Backed Bond - Nov 3rd, 2023 5:15 pm
Novo Integrated Sciences’ Board of Directors Approves $5 Million Stock Repurchase Program - Oct 24th, 2023 8:30 pm
Novo Integrated Sciences Provides Update on Certain Current Events - Oct 6th, 2023 1:00 pm
Novo Integrated Sciences Signs Master Collateral Transfer Agreement - Sep 28th, 2023 8:15 pm
Novo Integrated Sciences’ IoNovo for Kids Granted Registration Number and Regulatory Approval by Turkey’s Ministry of Health - Sep 13th, 2023 8:05 pm
Novo Integrated Sciences Provides Update on Potential Share Repurchase Program - Sep 8th, 2023 1:00 pm